# NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer

> **NCT01369420** · PHASE2 · COMPLETED · sponsor: **Angiodynamics, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DEVICE:** NanoKnife Low Energy Direct Current (LEDC) System Ablation

## Key facts

- **NCT ID:** NCT01369420
- **Lead sponsor:** Angiodynamics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-12
- **Final completion:** 2012-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2016-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01369420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01369420, "NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01369420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*